Lv4
680 积分 2025-05-22 加入
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
1个月前
已完结
A review of survodutide: a new dual acting agonist
1个月前
已完结
Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis
2个月前
已完结
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2个月前
已完结
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2个月前
已完结
American Association of Clinical Endocrinologists and American College of Endocrinology Consensus Conference on Obesity: Building an Evidence Base for Comprehensive Action
2个月前
已完结
Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery
2个月前
已完结
Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials
4个月前
已完结
[求助补充材料] New England Journal of Medicine (NEJM) Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis - Protocol (nejmoa2413258_protocol.pdf)
8个月前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis - Protocol (nejmoa2413258_protocol.pdf)
9个月前
已完结
皖公网安备34019202002308
